Herbas VPB

Print
EN | LT
LT - Imunoglobulino chimeriniai monomeriniai-dimeriniai hibridai
EN - IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 14/505 (2006.01)
C07K 14/555 (2006.01)
C07K 14/56 (2006.01)
C07K 14/565 (2006.01)
C07K 14/745 (2006.01)
C07K 14/475 (2006.01)
C07K 16/00 (2006.01)
C12N 9/64 (2006.01)
C12N 9/96 (2006.01)
A61K 47/48 (2006.01)
European patent
(11) Number of the document 2361932
(13) Kind of document T
(96) European patent application number 10182890.3
Date of filing the European patent application 2004-05-06
(97) Date of publication of the European application 2011-08-31
(45) Date of publication and mention of the grant of the patent 2016-05-04
(46) Date of publication of the claims translation 2016-07-25
Priority applications
(30) Number Date Country code
469600 P 2003-05-06 US
487964 P 2003-07-17 US
539207 P 2004-01-26 US
Inventors
(72)
Peters, Robert T., US
Mezo, Adam R, US
Rivera, Daniel S, US
Bitonti, Alan J, US
Stattel, James M, US
Low, Susan C, US
Grantee
(73) Bioverativ Therapeutics Inc., 225 Second Avenue, Waltham, MA 02451, US
Attorney or representative
(74) Genė Ona SRUOGIENĖ, UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius, LT
Title
(54) Imunoglobulino chimeriniai monomeriniai-dimeriniai hibridai
  IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
Last renewal fee
Payment date Validity (years) Amount
2022-04-15 19 347.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2023-05-06